IR情報

2019/06/14~2019/11/11

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2019
11/11520524517520+0.58%6,317,2008608億3201万+3.59%
11/08518522514517+0.78%9,576,9008558億6567万+3.19%
11/07513517510513-0.58%6,428,5008492億4388万+2.6%
11/06514517511516+0.98%6,789,9008542億1022万+3.41%
11/05510514506511+2%9,661,3008459億3299万+2.61%
11/01495501492501+0.4%6,551,3008293億7853万+0.6%
10/3122:25 当社子会社によるRoivant Sciencesとの戦略的提携に関する正式契約の締結について
10/31496502490499+0.2%9,160,3008260億6764万+0.4%
10/3014:30 2020年3月期第2四半期決算短信〔IFRS〕(連結)
10/30502504494498-1.39%12,997,1008244億1219万0%
10/29503505500505+1.61%8,246,6008360億31万+1.41%
10/28499502495497+0.61%5,807,0008227億5674万-0.2%
10/25504505492494-1.2%9,799,8008177億9041万-0.8%
10/24492501491500+1.83%10,029,4008277億2308万+0.4%
10/23492496487491-3.16%15,495,6008128億2407万-1.6%
10/2115:00 第2四半期業績予想および通期業績予想の修正ならびに配当予想の修正に関するお知らせ
10/21507511507507-0.78%4,566,7008393億1121万+1.4%
10/18506513505511+0.79%6,372,6008459億3299万+2.2%
10/175125125055070%4,715,9008393億1121万+1.6%
10/16515518506507-0.2%7,885,8008393億1121万+1.81%
10/15511512506508+0.79%7,509,0008409億6665万+2.21%
10/11498504494504+2.23%6,534,9008343億4487万+1.61%
10/10494496485493+0.41%6,974,9008161億3496万-0.4%
10/09486492484491-0.61%6,007,7008128億2407万-0.61%
10/08487497487494+2.28%8,199,8008177億9041万+0.2%
10/07488489482483-0.21%3,997,5007995億8050万-1.83%
10/04487488480484-0.62%5,653,3008012億3594万-1.43%
10/03485489484487-1.81%6,928,4008062億228万-0.61%
10/02492498491496-0.2%5,793,9008211億130万+1.43%
10/01488499488497+2.47%7,037,4008227億5674万+2.05%
09/30490495485485-1.62%6,757,2008028億9139万-0.21%
09/308:45 ニューファーム社の南米グループ会社の株式取得に関するお知らせ
09/27496497485493-2.57%9,024,6008161億3496万+1.65%
09/26509514504506+1.2%9,541,1008376億5576万+4.55%
09/25501502494500-0.79%6,130,6008277億2308万+3.73%
09/24501508501504+1%6,441,4008343億4487万+4.78%
09/20506506498499-0.99%9,847,8008260億6764万+4.18%
09/19509514502504-0.59%8,193,1008343億4487万+5.66%
09/18503510502507+1.4%8,923,0008393億1121万+6.51%
09/17512515500500-2.91%11,949,7008277億2308万+5.49%
09/13512517506515+0.78%9,751,4008525億5478万+9.11%
09/12516518511511+0.39%8,397,7008459億3299万+8.72%
09/11505513505509+1.8%9,838,2008426億2210万+8.76%
09/10489500488500+3.09%7,661,0008277億2308万+7.3%
09/09480485479485+0.62%4,021,1008028億9139万+4.3%
09/0611:30 当社子会社によるRoivant Sciencesとの戦略的提携に関する基本合意書の締結について
09/06482486482482+0.63%5,796,3007979億2505万+3.88%
09/05469480469479+3.23%7,527,5007929億5871万+3.01%
09/04466467461464-1.07%4,410,8007681億2702万-0.43%
09/03466472465469+1.08%4,588,0007764億425万+0.43%
09/02460465460464-0.22%4,246,0007681億2702万-0.85%
08/30463466460465+1.09%6,774,6007697億8247万-0.85%
08/29460462456460-0.22%4,163,1007615億524万-2.13%
08/28460464456461+0.66%6,060,5007631億6068万-2.33%
08/274634674554580%9,450,2007581億9434万-3.17%
08/26449460448458-1.29%9,123,1007581億9434万-3.38%
08/23468469463464-0.22%5,069,2007681億2702万-2.32%
08/22466467463465+0.43%4,882,0007697億8247万-2.31%
08/21463467460463-1.07%4,249,1007664億7157万-2.94%
08/20467470464468+0.43%4,988,9007747億4881万-2.09%
08/19467472464466+1.08%6,968,7007714億3791万-2.71%
08/16454462453461+0.44%6,282,0007631億6068万-3.96%
08/15452461450459-1.5%7,612,9007598億4979万-4.57%
08/14461468460466+2.87%9,657,3007714億3791万-3.32%
08/13454455450453-2.37%7,685,0007499億1711万-6.4%
08/09464466458464+0.87%7,353,1007681億2702万-4.53%
08/08457461452460+0.22%7,949,3007615億524万-5.74%
08/07461463456459-0.86%7,227,5007598億4979万-6.33%
08/06446463443463+0.43%12,086,5007664億7157万-5.89%
08/05466466452461-2.74%12,602,4007631億6068万-6.68%
08/02486486473474-5.39%13,582,6007846億8148万-4.44%
08/01491504490501+0.2%8,969,4008293億7853万+0.8%
07/3115:30 2020年3月期第1四半期決算短信〔IFRS〕(連結)
07/31492501492500+1.01%7,430,6008277億2308万+0.81%
07/30490498490495+1.23%6,275,4008194億4585万-0.2%
07/294904904834890%6,451,7008095億1318万-1.41%
07/26492495488489-1.01%6,162,4008095億1318万-1.21%
07/25499499492494-0.6%4,388,9008177億9041万-0.2%
07/24498500495497+0.2%5,014,0008227億5674万+0.4%
07/23490499487496+1.02%6,045,7008211億130万+0.4%
07/22490495489491+0.82%4,401,3008128億2407万-0.41%
07/19480489477487+1.46%5,107,7008062億228万-1.22%
07/18485491478480-2.24%7,144,8007946億1416万-2.64%
07/17485493483491+0.41%5,888,4008128億2407万-0.41%
07/16488490485489-0.81%4,616,5008095億1318万-0.81%
07/12492496490493+0.41%3,907,5008161億3496万0%
07/11483492481491+1.66%5,424,9008128億2407万-0.41%
07/10490491483483-2.42%10,639,4007995億8050万-1.83%
07/09499507495495-2.75%8,136,7008194億4585万+0.61%
07/08514516509509-0.39%4,958,7008426億2210万+3.67%
07/055135155115110%3,834,0008459億3299万+4.5%
07/04508514508511+1.19%4,827,5008459億3299万+4.71%
07/03508509502505-1.75%6,450,4008360億31万+3.7%
07/0213:00 当社子会社による開発中の抗がん剤ナパブカシンの膵がんを対象としたフェーズ3試験(CanStem111P試験)の中止について
07/02514516511514-0.19%5,215,1008508億9933万+5.98%
07/01509516503515+3%7,603,6008525億5478万+6.4%
06/28503503496500+0.2%7,410,1008277億2308万+3.52%
06/27486500485499+3.31%8,573,5008260億6764万+3.53%
06/26483486479483-0.62%6,904,3007995億8050万+0.42%
06/25491492485486-0.82%6,108,1008045億4684万+1.04%
06/24490491486490+0.41%4,346,8008111億6862万+1.66%
06/21483492482488+0.83%9,362,5008078億5773万+1.24%
06/20487487479484-0.62%9,064,3008012億3594万+0.41%
06/19483488478487+2.53%7,928,4008062億228万+0.83%
06/18479481473475-1.04%6,801,3007863億3693万-1.86%
06/17480484478480-0.41%6,852,9007946億1416万-1.23%
06/14481485478482-0.41%5,988,4007979億2505万-0.82%